Table 1.
Characteristic | Overall |
The frequency of cannabis use |
||
---|---|---|---|---|
N (%) | ≥3-5 times/wk | ≤1-2 times/wk | P value | |
Total | 325 | 283 | 42 | |
Age (years) | .128 | |||
<30 | 47 (14.5) | 46 (16.3) | 1 (2.4) | |
30–39 | 74 (22.8) | 62 (21.9) | 12 (28.6) | |
40–49 | 63 (19.4) | 51 (18.0) | 12 (28.6) | |
50–59 | 53 (16.3) | 47 (16.6) | 6 (14.3) | |
60+ | 83 (25.5) | 72 (25.4) | 11 (26.2) | |
Unknown | 5 (1.5) | 5 (1.8) | 0 (0.0) | |
Race | .693 | |||
White | 231 (71.1) | 202 (71.4) | 29 (69.0) | |
Black/African | 19 (5.8) | 15 (5.3) | 4 (9.5) | |
Hispanic/Latino | 44 (13.5) | 38 (13.4) | 6 (14.3) | |
Other | 31 (9.5) | 28 (9.9) | 3 (7.1) | |
Home region | .187 | |||
US West | 115 (35.4) | 104 (36.7) | 11 (26.2) | |
International | 39 (12.0) | 31 (11.0) | 8 (19.0) | |
US Midwest | 35 (10.8) | 27 (9.5) | 8 (19.0) | |
US Northeast | 70 (21.5) | 64 (22.6) | 6 (14.3) | |
US South | 60 (18.5) | 52 (18.4) | 8 (19.0) | |
Unknown | 6 (1.8) | 5 (1.8) | 1 (2.4) | |
Relationship status | .479 | |||
Married | 171 (52.6) | 147 (51.9) | 24 (57.1) | |
In a relationship | 67 (20.6) | 62 (21.9) | 5 (11.9) | |
Single | 86 (26.5) | 73 (25.8) | 13 (31.0) | |
Unknown | 1 (0.3) | 1 (0.4) | 0 (0.0) | |
Weight (mean (SD)) | 191.52 (47.02) | 189.32 (43.70) | 206.38 (63.86) | .028 |
Height (mean (SD)) | 178.16 (8.11) | 177.90 (8.03) | 180.04 (8.50) | .149 |
The number of PCP visits in the last 3 months | .197 | |||
0 | 170 (52.3) | 153 (54.1) | 17 (40.5) | |
1 | 108 (33.2) | 92 (32.5) | 16 (38.1) | |
2+ | 47 (14.5) | 38 (13.4) | 9 (21.4) | |
Tobacco smoking history | .118 | |||
Never smoker | 118 (36.3) | 97 (34.3) | 21 (50.0) | |
Current smoker | 52 (16.0) | 48 (17.0) | 4 (9.5) | |
Former smoker | 155 (47.7) | 138 (48.8) | 17 (40.5) | |
Cannabis use frequency | <.001 | |||
0 times/week | 13 (4.0) | 0 (0.0) | 13 (31.0) | |
1-2 times/week | 29 (8.9) | 0 (0.0) | 29 (69.0) | |
3-5 times/week | 51 (15.7) | 51 (18.0) | 0 (0.0) | |
6+ times/week | 232 (71.4) | 232 (82.0) | 0 (0.0) | |
The primary method of consumption | <.001 | |||
Smoking flower | 174 (53.5) | 157 (55.5) | 17 (40.5) | |
Edibles | 21 (6.5) | 17 (6.0) | 4 (9.5) | |
Smoking concentrates or extracts | 28 (8.6) | 26 (9.2) | 2 (4.8) | |
Tincture or oils | 28 (8.6) | 21 (7.4) | 7 (16.7) | |
Unknown | 4 (1.2) | 0 (0.0) | 4 (9.5) | |
Vaping | 57 (17.5) | 53 (18.7) | 4 (9.5) | |
Other | 13 (4.0) | 9 (3.2) | 4 (9.5) | |
Cannabis chemovar | <.001 | |||
THC dominant | 193 (59.4) | 173 (61.1) | 20 (47.6) | |
CBD:THC 1:1 | 96 (29.5) | 89 (31.4) | 7 (16.7) | |
CBD dominant | 30 (9.2) | 21 (7.4) | 9 (21.4) | |
Unknown | 6 (1.8) | 0 (0.0) | 6 (14.3) | |
The primary reason for use | .001 | |||
Medical | 249 (76.6) | 226 (79.9) | 23 (54.8) | |
Adult use | 76 (23.4) | 57 (20.1) | 19 (45.2) | |
IIEF scores (mean (SD)) | ||||
Overall score | 64.74 (9.10) | 65.36 (8.02) | 60.52 (13.84) | .001 |
Erectile domain | 27.12 (4.42) | 27.32 (4.10) | 25.74 (6.04) | .03 |
Orgasm domain | 8.95 (1.66) | 9.08 (1.42) | 8.12 (2.66) | <.001 |
Sexual desire domain | 8.42 (1.60) | 8.43 (1.50) | 8.31 (2.20) | .638 |
Intercourse satisfaction domain | 12.27 (2.45) | 12.42 (2.26) | 11.31 (3.37) | .006 |
Overall satisfaction domain | 7.97 (2.05) | 8.11 (1.87) | 7.05 (2.87) | .002 |
Erectile dysfunction (SHIM < 21) | 63 (19.4) | 50 (17.7) | 13 (31.0) | .068 |
Total comorbidities | .021 | |||
0 | 106 (32.6) | 94 (33.2) | 12 (28.6) | |
1 | 92 (28.3) | 72 (25.4) | 20 (47.6) | |
2 | 64 (19.7) | 60 (21.2) | 4 (9.5) | |
3+ | 63 (19.4) | 57 (20.1) | 6 (14.3) |
Comorbidities assessed included hypertension, diabetes, heart disease, arthritis, lung disease, kidney disease, thyroid disease, hypercholesterolemia, cancer, neurologic disease, liver disease, depression, and anxiety.
US = the United States; PCP = primary care physician, THC = tetrahydrocannabinol, CBD = cannabidiol, IIEF = International Index of Erectile Function; SHIM = Sexual Health Inventory for Men.